{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:36:19Z","timestamp":1793090179704,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011488","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105543","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:11:44Z","timestamp":1786633904000},"page":"105543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ZEB1 orchestrates cellular plasticity and therapy resistance in prostate cancer: From molecular mechanisms to clinical targeting"],"prefix":"10.1016","volume":"227","author":[{"given":"Qianqian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhankui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-056X","authenticated-orcid":false,"given":"Honglian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105543_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.04.044","article-title":"Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c","volume":"431","author":"Abisoye-Ogunniyan","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105543_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108255","article-title":"Current and emerging therapies for neuroendocrine prostate cancer","volume":"238","author":"Alabi","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105543_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eururo.2025.01.010","article-title":"Combination therapies in locally advanced and metastatic hormone-sensitive prostate cancer","volume":"87","author":"Azad","year":"2025","journal-title":"Eur. Urol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105543_bib4","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/carcin\/bgs285","article-title":"Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models","volume":"33","author":"Becker-Santos","year":"2012","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105543_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122947","article-title":"Zeb1 and SK3 channel are up-regulated in castration-resistant prostate cancer and promote neuroendocrine differentiation","volume":"13","author":"Bery","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105543_bib6","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/embor.2008.74","article-title":"A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells","volume":"9","author":"Burk","year":"2008","journal-title":"EMBO Rep."},{"issue":"43","key":"10.1016\/j.critrevonc.2026.105543_bib8","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1038\/onc.2011.612","article-title":"SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis","volume":"31","author":"Byles","year":"2012","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib9","first-page":"65","article-title":"Deciphering the prognostic significance and regulatory networks of ZEB1 and ZEB2 in prostate adenocarcinoma","volume":"7","author":"Caldiran","year":"2024","journal-title":"Exp. Biomed. Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105543_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/pros.24655","article-title":"Variable effects of periprostatic adipose tissue on prostate cancer cells: role of adipose tissue lipid composition and cancer cells related factors","volume":"84","author":"Cancel","year":"2024","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccr.2011.06.016","article-title":"Coordinated regulation of polycomb group complexes through microRNAs in cancer","volume":"20","author":"Cao","year":"2011","journal-title":"Cancer Cell."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105543_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/pros.23183","article-title":"MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis","volume":"76","author":"Cha","year":"2016","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105543_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/genes12121900","article-title":"Epithelial-mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics","volume":"12","author":"Chaves","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2026.105543_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.phrs.2017.07.009","article-title":"Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating \u03b2-catenin","volume":"123","author":"Chen","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.critrevonc.2026.105543_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/351089","article-title":"Matricellular proteins: a sticky affair with cancers","volume":"2012","author":"Chong","year":"2012","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/ERC-13-0548","article-title":"RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization","volume":"21","author":"Chu","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105543_bib17","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.7150\/thno.36735","article-title":"Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-\u03b2 signaling","volume":"9","author":"Dai","year":"2019","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105543_bib18","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1007\/s11033-020-05918-1","article-title":"Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line","volume":"47","author":"Deezagi","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"27","key":"10.1016\/j.critrevonc.2026.105543_bib19","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1038\/onc.2012.334","article-title":"Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis","volume":"32","author":"Dong","year":"2013","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105543_bib20","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1091\/mbc.e08-10-1076","article-title":"ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells","volume":"20","author":"Drake","year":"2009","journal-title":"Mol. Biol. Cell."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105543_bib21","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.21873\/anticanres.13357","article-title":"The epigenetic modifier 5-Aza-2-deoxycytidine triggers the expression of CD146 gene in prostate cancer cells","volume":"39","author":"Dudzik","year":"2019","journal-title":"Anticancer. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mc.22528","article-title":"Zinc finger E-box binding homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+\/H+ Exchanger-1 (NHE1)","volume":"56","author":"Dykes","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105543_bib23","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-18-2993","article-title":"MiR-644a disrupts oncogenic transformation and warburg effect by direct modulation of multiple genes of tumor-promoting pathways","volume":"79","author":"Ebron","year":"2019","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105543_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells11243993","article-title":"SCAND1 reverses epithelial-to-mesenchymal transition (EMT) and suppresses prostate cancer growth and migration","volume":"11","author":"Eguchi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105543_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2017.02.033","article-title":"miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis","volume":"395","author":"El Bezawy","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13046-019-1060-z","article-title":"miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKC\u03b5 and ZEB1 inhibition","volume":"38","author":"El Bezawy","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijpharm.2017.09.013","article-title":"Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours","volume":"532","author":"Evans","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29829-1","article-title":"The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer","volume":"8","author":"Farf\u00e1n","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib29","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ajpath.2019.02.017","article-title":"Functional organotypic cultures of prostate tissues: a relevant preclinical model that preserves hypoxia sensitivity and calcium signaling","volume":"189","author":"Figiel","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105543_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.humpath.2016.10.013","article-title":"Clinical significance of epithelial-mesenchymal transition markers in prostate cancer","volume":"61","author":"Figiel","year":"2017","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/path.5754","article-title":"Lipophagy and prostate cancer: association with disease aggressiveness and proximity to periprostatic adipose tissue","volume":"255","author":"Fontaine","year":"2021","journal-title":"J. Pathol."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105543_bib32","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1128\/MCB.21.24.8461-8470.2001","article-title":"The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation","volume":"21","author":"Fontemaggi","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/17435390.2024.2307616","article-title":"Cationic solid lipid nanoparticles (SLN) complexed with plasmid DNA enhance prostate cancer cells (PC-3) migration","volume":"18","author":"Garcia-Fossa","year":"2024","journal-title":"Nanotoxicology"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105543_bib34","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1158\/0008-5472.CAN-07-2559","article-title":"Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells","volume":"68","author":"Graham","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3892\/ol.2015.3943","article-title":"Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK\/MAPK and Zeb-1 signaling pathway","volume":"11","author":"Han","year":"2016","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105543_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1878-0261.12030","article-title":"The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer","volume":"11","author":"Hanrahan","year":"2017","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib37","first-page":"1275","article-title":"Silencing of the transcriptional factor ZEB1 alters the steroidogenic pathway, and increases the concentration of testosterone and DHT in DU145 cells","volume":"41","author":"Herrera","year":"2019","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib38","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3892\/mmr.2015.4733","article-title":"SET8 induces epithelial\u2011mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1","volume":"13","author":"Hou","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.critrevonc.2026.105543_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.chemphyslip.2016.02.011","article-title":"Cholesterol homeostasis: how do cells sense sterol excess?","volume":"199","author":"Howe","year":"2016","journal-title":"Chem. Phys. Lipids"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/15384047.2014.987078","article-title":"The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer","volume":"16","author":"Huang","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamaoncol.2024.0591","article-title":"Metastatic hormone-sensitive prostate cancer and combination treatment outcomes: a review","volume":"10","author":"Hussain","year":"2024","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063332","article-title":"Overexpression of REST represses the epithelial-mesenchymal transition process and decreases the aggressiveness of prostate cancer cells","volume":"25","author":"Indo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105543_bib44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.21873\/cgp.20397","article-title":"H19 in serum extracellular vesicles reflects resistance to AR axis-targeted therapy among CRPC patients","volume":"20","author":"Kato","year":"2023","journal-title":"Cancer Genom. Proteom."},{"issue":"44","key":"10.1016\/j.critrevonc.2026.105543_bib45","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/onc.2013.461","article-title":"TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c","volume":"33","author":"Kim","year":"2014","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib46","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/jcb.24464","article-title":"Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer","volume":"114","author":"Kim","year":"2013","journal-title":"J. Cell. Biochem."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105543_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312840","article-title":"Reduced Zeb1 expression in prostate cancer cells leads to an aggressive partial-EMT phenotype associated with altered global methylation patterns","volume":"22","author":"Kitz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105543_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045045","article-title":"Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells","volume":"7","author":"Kong","year":"2012","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105543_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10030098","article-title":"Estrogen receptor \u03b1 is crucial in zearalenone-induced invasion and migration of prostate cancer cells","volume":"10","author":"Kowalska","year":"2018","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tips.2016.03.003","article-title":"Improving taxane-based chemotherapy in castration-resistant prostate cancer","volume":"37","author":"Kroon","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105543_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081480","article-title":"Investigating the role of SNAI1 and ZEB1 expression in prostate cancer progression and immune modulation of the tumor microenvironment","volume":"16","author":"Lautert-Dutra","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13062-023-00393-7","article-title":"Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer","volume":"18","author":"Le Hars","year":"2023","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib53","article-title":"Androgen action in cell fate and communication during prostate development at single-cell resolution","volume":"148","author":"Lee","year":"2021","journal-title":"Development"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105543_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021650","article-title":"TMPRSS2\/ERG promotes epithelial to mesenchymal transition through the ZEB1\/ZEB2 axis in a prostate cancer model","volume":"6","author":"Leshem","year":"2011","journal-title":"PLOS One"},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105543_bib55","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/pros.24234","article-title":"Tissue cholesterol metabolism and prostate cancer aggressiveness: Ethno-geographic variations","volume":"81","author":"Lethongsavarn","year":"2021","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib56","first-page":"1715","article-title":"miR-205-5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10585-019-09958-1","article-title":"The role of heterogeneous environment and docetaxel gradient in the emergence of polyploid, mesenchymal and resistant prostate cancer cells","volume":"36","author":"Lin","year":"2019","journal-title":"Clin. Exp. Metastas-.-."},{"key":"10.1016\/j.critrevonc.2026.105543_bib58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-031-12974-2_2","article-title":"The transcription factors Zeb1 and snail induce cell malignancy and cancer stem cell phenotype in prostate cells, increasing androgen synthesis capacity and therapy resistance","volume":"1393","author":"L\u00f3pez-Moncada","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4103\/aja.aja_23_19","article-title":"Secreted protein acidic and rich in cysteine (SPARC) induces epithelial-mesenchymal transition, enhancing migration and invasion, and is associated with high Gleason score in prostate cancer","volume":"21","author":"L\u00f3pez-Moncada","year":"2019","journal-title":"Asian J. Androl."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105543_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115874","article-title":"SPARC induces E-cadherin repression and enhances cell migration through integrin \u03b1v\u03b23 and the transcription factor ZEB1 in prostate cancer cells","volume":"23","author":"L\u00f3pez-Moncada","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105543_bib61","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/carcin\/bgab101","article-title":"DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer","volume":"42","author":"Mancini","year":"2021","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105543_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081152","article-title":"A novel splice variant of the inhibitor of growth 3 lacks the plant homeodomain and regulates epithelial-mesenchymal transition in prostate cancer cells","volume":"11","author":"Melekhova","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105543_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug. Resist. Updat."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105543_bib64","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/pros.23177","article-title":"MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence","volume":"76","author":"Nam","year":"2016","journal-title":"Prostate"},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105543_bib65","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1089\/scd.2021.0043","article-title":"Reduced DAPK1 expression promotes stem cell-like characteristics of prostate cancer cells by activating ZEB1 via Hippo\/YAP signaling pathway","volume":"30","author":"Nong","year":"2021","journal-title":"Stem Cells Dev."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105543_bib66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/aja.aja_61_17","article-title":"The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines","volume":"20","author":"Orellana-Serradell","year":"2018","journal-title":"Asian J. Androl."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105543_bib67","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4103\/aja.aja_1_19","article-title":"The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines","volume":"21","author":"Orellana-Serradell","year":"2019","journal-title":"Asian J. Androl."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105543_bib68","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/onc.2011.312","article-title":"Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate","volume":"31","author":"Orr","year":"2012","journal-title":"Oncogene"},{"issue":"46","key":"10.1016\/j.critrevonc.2026.105543_bib69","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1038\/onc.2015.498","article-title":"Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties","volume":"35","author":"Paranjape","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13062-025-00604-3","article-title":"Dualistic role of ZEB1 and ZEB2 in tumor progression","volume":"20","author":"Parfenyev","year":"2025","journal-title":"Biol. Direct"},{"key":"10.1016\/j.critrevonc.2026.105543_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.588544","article-title":"\u03b1-actinin-4 promotes the progression of prostate cancer through the Akt\/GSK-3\u03b2\/\u03b2-catenin signaling pathway","volume":"8","author":"Park","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105543_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315127","article-title":"Post-translational modification of ZEB family members in cancer progression","volume":"23","author":"Park","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105543_bib73","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105543_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2012.20","article-title":"Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition","volume":"1","author":"Pellecchia","year":"2012","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10585-021-10075-1","article-title":"Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers","volume":"38","author":"Pereira-Veiga","year":"2021","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105543_bib76","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8009","article-title":"Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells","volume":"45","author":"P\u00e9rez","year":"2021","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105543_bib77","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ijc.31379","article-title":"CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease","volume":"143","author":"Porretti","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105543_bib78","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/emboj\/cdg225","article-title":"Opposing functions of ZEB proteins in the regulation of the TGFbeta\/BMP signaling pathway","volume":"22","author":"Postigo","year":"2003","journal-title":"Embo J."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105543_bib79","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1128\/MCB.19.12.7961","article-title":"Independent repressor domains in ZEB regulate muscle and T-cell differentiation","volume":"19","author":"Postigo","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105543_bib80","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/carcin\/bgu183","article-title":"PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis","volume":"35","author":"Pu","year":"2014","journal-title":"Carcinogenesis"},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105543_bib81","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105543_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076773","article-title":"Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer","volume":"8","author":"Roca","year":"2013","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib83","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jcb.27446","article-title":"ETS1 induces transforming growth factor \u03b2 signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells","volume":"120","author":"Rodgers","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105543_bib84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13205-024-03941-8","article-title":"An insight into the diagnostic, prognostic, and taxanes resistance of double zinc finger and homeodomain factor's expression in na\u00efve prostate cancer","volume":"14","author":"Said","year":"2024","journal-title":"3 Biotech"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105543_bib85","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/pros.22758","article-title":"Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression","volume":"74","author":"Saraon","year":"2014","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib86","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/onc.2016.185","article-title":"A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer","volume":"36","author":"Selth","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105543_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.928399","article-title":"Opposing roles of wild-type and mutant p53 in the process of epithelial to mesenchymal transition","volume":"9","author":"Semenov","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"6933","key":"10.1016\/j.critrevonc.2026.105543_bib88","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nature01550","article-title":"Coordinated histone modifications mediated by a CtBP co-repressor complex","volume":"422","author":"Shi","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105543_bib89","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11684-014-0353-z","article-title":"Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism","volume":"8","author":"Shi","year":"2014","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105543_bib90","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2174\/1568009621666210601114631","article-title":"Role of ZEB family members in proliferation, metastasis, and chemoresistance of prostate cancer cells: revealing signaling networks","volume":"21","author":"Soleymani","year":"2021","journal-title":"Curr. Cancer Drug. Targets"},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105543_bib91","first-page":"4032","article-title":"ZEB1 promotes prostate cancer proliferation and invasion through ERK1\/2 signaling pathway","volume":"21","author":"Song","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib92","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12943-017-0711-y","article-title":"Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer","volume":"16","author":"Su","year":"2017","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105543_bib93","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physiolgenomics.00062.2019","article-title":"LncRNA IUR downregulates ZEB1 by upregulating miR-200 to inhibit prostate carcinoma","volume":"51","author":"Sun","year":"2019","journal-title":"Physiol. Genom."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105543_bib94","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jjco\/hyv027","article-title":"miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1","volume":"45","author":"Sun","year":"2015","journal-title":"Jpn J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib95","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1158\/0008-5472.CAN-11-3004","article-title":"Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy","volume":"72","author":"Sun","year":"2012","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105543_bib96","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/09168451.2018.1537775","article-title":"Sika deer (Cervus nippon) velvet antler extract attenuates prostate cancer in xenograft model","volume":"83","author":"Tang","year":"2019","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105543_bib97","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/978-94-024-1079-2_96","article-title":"Taurine Attenuates epithelial-mesenchymal transition-related genes in human prostate cancer cells","volume":"975","author":"Tang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"38","key":"10.1016\/j.critrevonc.2026.105543_bib98","doi-asserted-by":"crossref","first-page":"15312","DOI":"10.1073\/pnas.1110977109","article-title":"Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer","volume":"109","author":"Tucci","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105543_bib99","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00018-008-8465-8","article-title":"The role of the ZEB family of transcription factors in development and disease","volume":"66","author":"Vandewalle","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"6907","key":"10.1016\/j.critrevonc.2026.105543_bib100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"issue":"7664","key":"10.1016\/j.critrevonc.2026.105543_bib101","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105543_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109557","article-title":"ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D","volume":"122","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib103","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41418-024-01295-5","article-title":"Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer","volume":"31","author":"Wang","year":"2024","journal-title":"Cell. Death Differ."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105543_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.07.005","article-title":"AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling","volume":"36","author":"Wang","year":"2018","journal-title":"Urol. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105543_bib105","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1111\/jcmm.13637","article-title":"ZEB1-mediated vasculogenic mimicry formation associates with epithelial-mesenchymal transition and cancer stem cell phenotypes in prostate cancer","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2015.03.025","article-title":"17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation","volume":"362","author":"Wang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105543_bib107","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10734","article-title":"Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF\/ERK signaling","volume":"5","author":"Wu","year":"2016","journal-title":"eLife"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105543_bib108","first-page":"3599","article-title":"microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1)","volume":"9","author":"Wu","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105543_bib109","first-page":"1545","article-title":"Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors","volume":"23","author":"Wu","year":"2010","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105543_bib110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pros.24647","article-title":"PrLZ regulates EMT and invasion in prostate cancer via the TGF-\u03b21\/p-smad2\/miR-200 family\/ZEB1 axis","volume":"84","author":"Xie","year":"2024","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105543_bib111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3892\/or.2016.4791","article-title":"Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma","volume":"36","author":"Xu","year":"2016","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105543_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110962","article-title":"Oncogenic role of SATB2 in vitro: regulator of pluripotency, self-renewal, and epithelial-mesenchymal transition in prostate cancer","volume":"13","author":"Yu","year":"2024","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105543_bib113","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccr.2010.03.018","article-title":"An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression","volume":"17","author":"Yu","year":"2010","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105543_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109177","article-title":"Vitamin D deficiency aggravates growth and metastasis of prostate cancer through promoting EMT in two \u03b2-catenin-related mechanisms","volume":"111","author":"Zhang","year":"2023","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105543_bib115","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biopha.2017.10.163","article-title":"miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1","volume":"97","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105543_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218243","article-title":"The Zeb1\/system X(c)(-) axis safeguards iron-loaded cancer-associated fibroblasts against ferroptosis and promotes immunosuppression in prostate cancer","volume":"639","author":"Zhang","year":"2026","journal-title":"Cancer Lett."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:53:15Z","timestamp":1793087595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":116,"alternative-id":["S1040842826004300"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105543","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZEB1 orchestrates cellular plasticity and therapy resistance in prostate cancer: From molecular mechanisms to clinical targeting","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105543"}}